Virtual Medicinal Product (VMP)
-
Amantadine 100mg capsules
Name Details
Current Name
Amantadine 100mg capsules
|
Start Date
28-10-2004
|
End Date
|
Previous Name
Amantadine 100mg capsules
|
Start Date
27-10-2003
|
End Date
27-10-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N04BB01
BNF |
Current BNF
04090100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04090100
|
Start Date
23-02-2005
|
End Date
03-04-2022
|
Previous BNF
05030400
|
Start Date
23-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42031011000001104 |
07-07-2023 |
|
323133000 |
28-10-2002 |
06-07-2023 |
VMP Ingredients
Name
Amantadine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100
Strength and UOM (Dmr)
Parent Products
-
VTM
Amantadine
-
VMP
(Current) Amantadine 100mg capsules
Virtual Medicinal Product Pack (VMPP) Information